Defunct Company
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
11,000
NCT06206369
Developing Trustworthy Artificial Intelligence (AI)-Driven Tools to Predict Vascular Disease Risk and Progression
Phase: N/A
Role: Collaborator
Start: Oct 31, 2023
Completion: May 1, 2029